fesoterodine, desfesoterodine
As the list published 23 Sept 2026 has it, binding since 16 Jun 2021. Each entry binds six months after its own publication date (Article 107c(7) of Directive 2001/83/EC).
What the list says
- EU reference date
- 20 Apr 2007
- PSUR frequency
- 5 years
- Data lock point
- 19 Apr 2030
- Submission date
- 18 Jul 2030
- Next data lock point
- Not stated
- Next submission date
- Not stated
- Products covered
- Centrally and nationally authorised (CAP and NAP)
Are PSURs required for products referred to in Articles 10(1), 10a and 16a of Directive 2001/83/EC?
No — the list does not require PSURs for these products.
The list asks this as one question for Articles 10(1), 10a and 16a together, and does not answer it for Article 14 at all. A PSUR may in any case be required at the request of a competent authority or as a condition of the marketing authorisation.
Notes in the list
PSUR frequency, DLP and reference to NAP were updated on 16/12/2020 PRAC Representative name was corrected on 29/07/2020 PRAC Representative updated on 26/09/2018 Entry name was amended on 06/06/2018 DLP was updated on 19/12/2017 PRAC Rapporteur name updated on 03/06/2016
Track dates like these for your own products: a sample workspace, read-only, no account needed.
Try the demoThe next three reports
- Data lock point 19 Apr 2030Submission by 18 Jul 2030
- Data lock point 19 Apr 2035Submission by 18 Jul 2035
- Data lock point 19 Apr 2040Submission by 18 Jul 2040
Counted from the data lock point the list gives, on the cycle it states: the submission date is 90 days after the data lock point — 70 days for a cycle of twelve months or less, 90 days for a longer one, as GVP Module VII sets out.
In earlier versions of the list
EMA/630645/2012 Rev.164 · published 23 Sept 2026
fesoterodine, desfesoterodine — every 5 years, data lock point 19 Apr 2030
EMA/630645/2012 Rev.156 · published 4 Feb 2026
fesoterodine, desfesoterodine — every 5 years, data lock point 19 Apr 2030
Source: European Medicines Agency, list of EU reference dates and frequency of submission of periodic safety update reports, EMA/630645/2012 Rev.164, published 23 Sept 2026. Open the published file
Kreastel is a planning and oversight aid for pharmacovigilance obligations. It tracks dates like these for a marketing authorisation holder's own products.
Report a discrepancy — if this page and the published file disagree, the file is right and we want to know.